v3.26.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Total Shareholders’ Equity
Ordinary Shares
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Beginning balance (in shares) at Apr. 28, 2023     1,331,000,000        
Beginning balance at Apr. 28, 2023 $ 51,665 $ 51,483 $ 0 $ 24,590 $ 30,392 $ (3,499) $ 182
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 3,705 3,676     3,676   28
Other comprehensive income (loss) 178 180       180 (2)
Dividends to shareholders (3,666) (3,666)     (3,666)    
Issuance of shares under stock purchase and award plans (in shares)     6,000,000        
Issuance of shares under stock purchase and award plans 231 231   231      
Repurchase of ordinary shares (in shares)     (25,000,000)        
Repurchase of ordinary shares (2,084) (2,084)   (2,084)      
Stock-based compensation 393 393   393      
Changes to noncontrolling ownership interests (2)           (2)
Ending balance (in shares) at Apr. 26, 2024     1,311,000,000        
Ending balance at Apr. 26, 2024 50,420 50,214 $ 0 23,129 30,403 (3,318) 206
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,691 4,662     4,662   29
Other comprehensive income (loss) (964) (966)       (966) 2
Dividends to shareholders (3,589) (3,589)     (3,589)    
Issuance of shares under stock purchase and award plans (in shares)     9,000,000        
Issuance of shares under stock purchase and award plans 440 440   440      
Repurchase of ordinary shares (in shares)     (38,000,000)        
Repurchase of ordinary shares (3,166) (3,166)   (3,166)      
Stock-based compensation 429 429   429      
Changes to noncontrolling ownership interests $ (6)           (6)
Ending balance (in shares) at Apr. 25, 2025 1,281,934,628   1,282,000,000        
Ending balance at Apr. 25, 2025 $ 48,256 48,024 $ 0 20,833 31,476 (4,284) 232
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,837 4,801     4,801   37
Other comprehensive income (loss) 181 183       183 (2)
Dividends to shareholders (3,639) (3,639)     (3,639)    
Issuance of shares under stock purchase and award plans (in shares)     8,000,000        
Issuance of shares under stock purchase and award plans 426 426   426      
Repurchase of ordinary shares (in shares)     (10,000,000)        
Repurchase of ordinary shares (944) (944)   (944)      
Stock-based compensation 457 457   457      
MiniMed IPO 538 157   157     381
Changes to noncontrolling ownership interests $ (39)           (39)
Ending balance (in shares) at Apr. 24, 2026 1,280,177,293   1,280,000,000        
Ending balance at Apr. 24, 2026 $ 50,072 $ 49,463 $ 0 $ 20,926 $ 32,638 $ (4,101) $ 609